Yasmine Maurice
Overview
Explore the profile of Yasmine Maurice including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miligy I, Badr N, Stevens A, Spooner D, Awasthi R, Mir Y, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000487
Oestrogen receptor (ER)-positive breast cancer (BC) is generally well responsive to endocrine therapy. Neoadjuvant endocrine therapy (NAET) is increasingly being used for downstaging ER-positive tumours. This study aims to analyse...
2.
Miligy I, Awasthi R, Mir Y, Khurana A, Sharma V, Chandaran U, et al.
Histopathology
. 2024 Jun;
85(3):405-417.
PMID: 38845397
Aims: Standard neoadjuvant endocrine therapy (NAET) is used for 6-9 months to downstage hormone-receptor-positive breast cancer. Bridging ET was introduced during the COVID-19 pandemic to delay surgical intervention. There are...
3.
Hughes G, Green C, Street D, Maurice Y, Henderson J, Woodhouse A, et al.
Am J Trop Med Hyg
. 2020 Jan;
102(3):574-577.
PMID: 31933459
Human infection with the trematode occurs with a worldwide prevalence of up to 17 million. Sheep and cattle are the normal host. Infection typically results in hepatobiliary disease, but extrahepatic...
4.
Masannat Y, Husain E, Roylance R, Heys S, Carder P, Ali H, et al.
Breast
. 2018 Jan;
38:120-124.
PMID: 29310036
Aims: Pleomorphic lobular carcinoma in situ (PLCIS) is a relatively newly described pathological lesion that is distinguished from classical LCIS by its large pleomorphic nuclei. The lesion is uncommon and...